The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.
HealthCast
Season 2
Episode 1
23m listen
Ensuring Participant Diversity in COVID-19 Vaccine Trials
Share
Modern technology has the power to overcome clinical trial participation challenges.
-
Dr. Jim Kublin Executive Director of Operation Programs CoVPN
Related Content
-
New OPM Database is First Step for Federal HR Modernization
OPM launched FWD, replacing FedScope with a more transparent, user-friendly platform featuring interactive workforce data.
8m listen -
Navy Pushes AI from Experiments to Everyday Warfighting Functions
The Navy’s hybrid fleet hinges on a common naval lexicon and trustworthy AI woven into every intelligence function.
6m watch -
Why Federal Experience Matters After Leaving Government
Jose Arrieta, former HHS CIO, discusses how federal civil servants can carry their high-stakes experience and resilience into careers beyond public service.
7m watch -
How the Marine Corps Is Building a High-Tech Future Fleet
The Marine Corps is leveraging AI to automate tedious tasks, enhance data readiness and accelerate mission-critical functions.
8m watch